IMMUNE DESIGN CORP. company info

CIK 1437786
IRS Number 262007174
State of incorporation DE
Business address 1616 EASTLAKE AVENUE E.
SUITE 310
SEATTLE
WA
98102
Mail address 601 GATEWAY BOULEVARD
SUITE 250
SOUTH SAN FRANCISCO
CA
94080

Short summary

IMMUNE DESIGN CORP. is a Washington company, with head office located at 1616 Eastlake Avenue E. Seattle, Washington 98102. In 2018 the company owned a total of 100.96 million USD worth of assets, including 100.22 million USD worth of current assets. 2014 was the year when the company amassed the most assets.

IMMUNE DESIGN CORP. Income Statement

Name [in Millions USD]20112012201320142015201620172018Trends
Cost of Goods and Services Sold 0.480.081.44
Research and development 8.6011.5522.7533.0945.1343.6742.42
Operating Expenses 13.8416.6636.3149.0067.4760.0159.25
Operating Income (Loss) -10.88-15.06-29.88-39.49-54.21-52.81-57.05
Other Nonoperating Income (Expense) 0.040.040.000.040.680.952.29
Net income -10.84-15.98-34.15-39.45-53.53-51.86-54.76

IMMUNE DESIGN CORP. Balance Sheet

Name [in Millions USD]20112012201320142015201620172018Trends
Cash and cash equivalents 12.014.8318.00129.0050.5335.3173.4377.94
Available-for-sale Securities, Current 42.0645.9646.8038.85
Accounts Receivable, Net, Current 1.040.880.380.500.660.71
Inventories 0.020.430.720.620.900.09
Property, Plant and Equipment, Gross 2.272.603.023.143.573.96
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment 1.972.202.442.733.083.42
Other Assets, Noncurrent 0.530.55
Total assets 22.08131.3497.7990.87124.73100.96
Current assets 20.03130.8597.3089.84123.98100.23
Accounts payable 1.372.023.534.253.161.48
Total current liabilities 2.866.2010.6617.257.908.85
Retained Earnings (Accumulated Deficit) -70.96-110.69-156.85-210.36-262.87-290.52

IMMUNE DESIGN CORP. Cash Flow

Name [in Millions USD]20112012201320142015201620172018Trends
Net income -10.84-15.98-34.15-39.45-53.53-51.86-54.76
Depreciation and amortization 0.550.410.240.240.300.350.35
Accounts receivable 0.45-0.431.88-1.00-0.460.130.06
Inventories 0.25-0.110.01-0.010.590.080.65
Accounts payable 0.50-0.216.04-3.831.49-2.23-0.86
Deferred revenue -0.512.50-2.55
Payments to Acquire Property, Plant, and Equipment 0.290.180.340.430.130.430.39
Net Cash Provided by (Used in) Investing Activities, Continuing Operations -0.29-0.13-0.34-0.43-62.42-7.0450.93
Proceeds from Issuance of Common Stock 0057.8175.3630.3186.620
Cash and Cash Equivalents, Period Increase (Decrease) 0.7517.6344.9737.57-67.7127.24